Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

MEBO Metabolic Malodor Survey (international) for Dr Hazen click here
click to Read more/less

survey for ANYONE who identifies with METABOLIC MALODOR

begun : Oct20
end : no ending for now

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

This is a GOOGLE FORMS survey

short url for survey :

current participants : 113 (update 18dec20)

Saturday, January 28, 2012

Halitology : A review paper

click to read halitology abstract
A paper has recently been published which seems to be an overview of halitosis, terming the subject 'halitology'. Professor Greenman has a long interest in halitosis, and is associated with ISBOR. Professor Scully is an esteemed dental surgeon.

Prof. Greenman is very likely aware of the work of Drs Wevers and Tangerman regarding dimethylsulfide being an 'extra-oral' cause of halitosis (eg, metabolic). Probably TMAU is mentioned in the overview too. There is a good chance it is a 'cutting edge' overview as far as allopathic medicine is concerned.

However, as halitosis sufferers are probably aware, there's a good chance it misses the 'transient metabolic' cases, where the person probably does not smell at a dental visit. Most of these people are likely to end up classed as 'halitophobic'. There must be a chance inclusion of 'transient metabolic' cases would change the estimates of each category by a considerable amount.

Unfortunately only the abstract is available to read for free.
Halitology : an overview (abstract on pubmed)


Larc400 said...

I've got hold of the full PDF. Will summarize when I've read it :).

Apr 27, 2012, 5:22:00 PM
Larc400 said...

This being a review, nothing new for those in the know. There is a section on TMAU and a list of other systemic causes.

Mainly it summarizes cause, effect and treatment of halitosis (oral origin) and compares various treatment regimes. The review does mention psycogenic halitosis, but points out that this is a diagnosis which shall only be applied after numerous visits and when all other causes are excluded.

There's also a small section on emerging treatments (for oral halitosis): probiotics, Fusobacterium nucleatum vaccines, myrsinoic acid (inhibits VSC production) and tea catechins (inhibits Porphyromas gingivalis and VSC production).

Apr 28, 2012, 7:15:00 AM
Post a Comment